Hello, Sign in
My Account
My Account
New customer? Start here
| Catalog # | Availability | Size | Quantity | Unit Price | Save For Later Wish List | |
|---|---|---|---|---|---|---|
| CYK0184-5 | 7 days | 5 µg | $120.00 |
Select product before adding to cart
|
||
| CYK0184-20 | 7 days | 20 µg | $290.00 | |||
| CYK0184-1 | 7 days | 1 mg | $4,320.00 |
Product Overview | |
| Name | IFIT3 Human |
|---|---|
| Description | |
| IFN-Induced Protein With Tetratricopeptide Repeats 3 Human Recombinant | |
| Accession (Primary) | O14879 |
| Introduction | |
| IFN-alpha 1b is produced by macrophages, IFN-alpha 1b has antiviral activities and stimulates the production of two enzymes: a protein kinase and an oligoadenylate synthetase. | |
| Source | |
| Escherichia Coli. | |
| Physical Appearance | |
| Sterile Filtered White lyophilized (freeze-dried) powder. | |
| Formulation | |
| Lyophilized from a 0.2 µm filtered solution (50ug/ml) in PBS, pH 7.4, containing 4% mannitol and 1% HSA. | |
| Stability | |
| Lyophilized Interferon alpha 1b although stable at room temperature for 3 weeks, should be stored desiccated below -18°C. Upon reconstitution IFN-alpha 1b should be stored at 4°C between 2-7 days and for future use below -18°C. For long term storage it is recommended to add a carrier protein (0.1% HSA or BSA). Please prevent freeze-thaw cycles. | |
| Purity | |
| Greater than 96.0% as determined by: (a) Analysis by RP-HPLC. (b) Analysis by SDS-PAGE. | |
| Amino acid sequence | |
| The sequence of the first five N-terminal amino acids was determined and was found to be Cys-Asp-Leu-Pro-Glu. | |
| Biological Activity | |
| The specific activity as determined in a viral resistance assay using bovine kidney MDBK cells was found to be 1 x 10 8 IU/ mg. | |
| Solubility | |
| It is recommended to reconstitute the lyophilized IFN alpha 1b in sterile 18MΩ-cm H2O not less than 100 µg/ml, which can then be further diluted to other aqueous solutions. | |
| Precautions | |
| IFIT3 Human is for research use only and not for use in diagnostic or therapeutic procedures. | |
Target Information: ( O14879 ) | |
Thousands of laboratories across the world have published research that depended on the performance of antibodies from ADMEbio to advance their research.
Check out links to articles that cite our products in major peer-reviewed journals, organized by research category.
Thank you,
ADMEbio Team
ADMEbio welcomes feedback from our customers.
Thank you,
ADMEbio Team
